- Meeting abstract
- Open Access
EHR4CR central workbench
© Voets; licensee BioMed Central Ltd. 2015
- Published: 22 May 2015
- Study Manager
- Clinical Site
- Recruitment Process
- Adverse Event Reporting
- Subject Identification
Tool, protocol feasibility, recruitment process, electronic data capture, multi-centric clinical trials.
The EHR4CR central workbench facilitates the patient recruitment process by offering workflow-driven administration and monitoring of the recruitment process for multi-centric trials. The study manager can select clinical sites of interest and invite them to participate in the study. Study metadata including protocol definition and formalized eligibility criteria queries are exchanged and synchronized with the participating clinical sites. The overall study status and individual clinical site participation status are continuously monitored and updated. The study manager is automatically informed about relevant changes occurring at each of the engaged clinical sites such as changes in the number of potential candidate patients, the number of consenting patients, patients in screening, included or excluded patients at each site.
In order to support clinical trial execution workflows, the EHR4CR central workbench will provide “Retrieve Form for Data Capture” (IHE-RFD)  capabilities (Form Manager, Form Receiver) to allow EDC systems to retrieve annotated eCRF forms that allow auto-population directly from the local EHR or clinical data warehouse.
Protocol feasibility functionality has been evaluated in three separate UAT rounds involving specialists from pharma and 11 pilot clinical sites. Subject identification and recruitment functionality is being evaluated. Support for clinical trial execution is still in development (November 2014).
Pharma, CRO (study designers, study managers).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.